Details for New Drug Application (NDA): 207438
✉ Email this page to a colleague
NDA 207438 describes METHAZOLAMIDE, which is a drug marketed by Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Mikart, Sandoz, and Tagi, and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the METHAZOLAMIDE profile page.
The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
Summary for 207438
| Tradename: | METHAZOLAMIDE |
| Applicant: | Bausch And Lomb Inc |
| Ingredient: | methazolamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 207438
Suppliers and Packaging for NDA: 207438
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METHAZOLAMIDE | methazolamide | TABLET;ORAL | 207438 | ANDA | Bausch & Lomb Incorporated | 24208-022 | 24208-022-01 | 1000 TABLET in 1 BOTTLE (24208-022-01) |
| METHAZOLAMIDE | methazolamide | TABLET;ORAL | 207438 | ANDA | Bausch & Lomb Incorporated | 24208-022 | 24208-022-10 | 100 TABLET in 1 BOTTLE (24208-022-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Oct 5, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Oct 5, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
